The Quantellect read.As of Nov 19, 2026, 22 active firms cover Insulet Corporation: 12 rate it Buy or better, 10 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $144.00 to $277.00, a moderate spread. The average target of $180.45 sits 29% above the current $140.04. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.66 next quarter toward $7.91 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS22 active firms
Buy
Strong Buy00%
Buy1255%
Neutral1045%
Sell00%
Strong Sell00%
Based on 22 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$180.45
+28.9% upside
Average target across 20 active firms as of Nov 19, 2026 vs $140.04 current
Highest Target$277.00
Average Target$180.45
Lowest Target$144.00
Detailed analyst forecasts for PODD
Showing 1–23 of 23 named analysts shown · 22 active firms in the rating projection
As of Nov 19, 2026, 12 of 22 active firms rate PODD a Buy (10 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PODD EPS & revenue forecast
EPS · NEXT QUARTER
$1.66
Range $1.40 – $1.78 · 18 analysts · +17% YoY
Next period, 18 analysts expect Insulet Corporation to earn $1.66 a share (range $1.40 – $1.78), versus $1.42 a year earlier. Full-year consensus is $6.77, growing to $7.91 the year after.
REVENUE · NEXT QUARTER
$851.3M
Range $827.0M – $878.5M · 18 analysts · +12% YoY
Revenue is expected to reach $851.3M (range $827.0M – $878.5M), +11.8% year-over-year. Full-year consensus is $3.3B, rising to $3.7B next year.
Top analysts covering Insulet Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PODD.
#1
Joanne Wuensch
Citigroup · Rank #35
Neutral
$150.00+7.1% to target
Overall win rate
51%
+ Follow
#2
JB
Jayson Bedford
Raymond James · Rank #191
Buy
$216.00+54.2% to target
Overall win rate
44%
+ Follow
#3
Jonathan Block
Stifel · Rank #294
Buy
$180.00+28.5% to target
Overall win rate
36%
+ Follow
#4
William Plovanic
Canaccord Genuity · Rank #370
Buy
$179.00+27.8% to target
Overall win rate
38%
+ Follow
#5
Bruce Jackson
Benchmark · Rank #487
Buy
$185.00+32.1% to target
Overall win rate
36%
+ Follow
PODD stock forecast FAQ
What is PODD's average 12-month price target?+
The 20 active firms with a live target average $180.45 for Insulet Corporation over the next 12 months, ranging from a $277.00 high to a $144.00 low, as of Nov 19, 2026.
Is PODD stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 22 active firms as of Nov 19, 2026, 12 rate it Buy or Strong Buy, 10 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for PODD?+
The Street-high target is $277.00 (Goldman Sachs), and the Street-low is $144.00 (TD Cowen). The average of all 20 active-firm targets is $180.45.
How many active Wall Street firms cover PODD?+
22 active firms have a recognized rating on Insulet Corporation as of Nov 19, 2026, and 20 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PODD?+
Among analysts who currently cover PODD, Joanne Wuensch of Citigroup has the strongest overall Quantellect track record (Rank #35). Their current call is Neutral with a $150.00 target.
What is Insulet Corporation's projected EPS for next quarter?+
The consensus estimate is $1.66 per share (range $1.40 – $1.78) across 18 analysts. Full-year EPS is projected at $6.77, rising to $7.91 the following year.
How much revenue is Insulet Corporation expected to report next quarter?+
Consensus revenue is $851.3M (range $827.0M – $878.5M). Full-year revenue is projected at $3.3B, growing to $3.7B next year.
Have analysts been upgrading or downgrading PODD lately?+
As of Nov 19, 2026, 12 of 22 active firms rate PODD a Buy (10 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PODD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.